• Staff
  • Board of Directors
  • Contact Us

Meridian Institute

GM Maize Could Produce Hepatitis B Vaccine

Summary posted by Meridian on 4/7/2004

Source: SciDev.Net

Author(s): Wagdy Sawahel

A team of Egyptian scientists has genetically engineered maize plants to produce the HbsAg protein, which elicits an immune response against the hepatitis B virus and could be used as a vaccine. More than two billion people are infected with hepatitis B, and about 350 million of those are at high risk of serious illness and death from liver damage or liver cancer. The Egyptian research team, led by Hania El-itriby, director of Cairo's Agricultural Genetic Engineering Research Institute, is now attempting to increase the amount of HbsAg protein produced by the genetically modified (GM) plants. A vaccine against hepatitis B is already available, but the researchers say that edible vaccines produced by GM plants would be cheaper and would not require refrigeration or skilled medical personnel. Reporting on the research results at a recent international conference on genetic engineering and biotechnology in Cairo, El-itriby said that producing cheap, effective vaccine against hepatitis B is vital, as many people cannot afford the current expensive vaccine. The researchers expect to begin tests of their vaccine's effectiveness on animals and humans in early 2005. The article can be viewed online at the link below.

The original article may still be available at http://www.scidev.net/News/index.cfm?fuseaction=readNews&itemid=1316&language=1

As tagged by Meridian Institute:

Stakeholders: GovernmentNGOAcademiaDonor

Regions: Asia

Topics: Socio-economic issuesScientific researchRisks and benefits: human healthProduct development

Food Security and AgBiotech News

  • Regulate Synthetic Biology Now: 194 Countries

    ETC Group (19 Oct 2014) (10/21/2014)

    According to the ETC Group, an organization that works to address the socioeconomic and ecological issues surrounding new technologies that could impact the world’s poorest and most vulnerable people,... more

  • Syngenta Faces More Suits Over Viptera Corn Seeds

    The Wall Street Journal (19 Oct 2014) (10/20/2014)

    Syngenta AG is facing even more lawsuits over its sale of genetically engineered corn seeds, known as Viptera, which some United States farmers and agricultural companies say have disrupted internatio... more

  • New Study Finds that Orange Maize Improves Vitamin A in Children

    HarvestPlus (16 Oct 2014) (10/20/2014)

    A new study, published in the American Journal of Clinical Nutrition, reports that “orange” vitamin A maize, which has been bred conventionally, increases vitamin A storage in the body. A lack of vita... more

  • Researchers Uncover Tomato's Genetic History

    Phys.org (14 Oct 2014) (10/20/2014)

    Scientists at the Chinese Academy of Agricultural Sciences have reconstructed the history of the tomato, from its origins in South America to the many varieties found worldwide today. The tomato is th... more

  • Principles for Responsible Agriculture and Food Investments Are Approved

    Food and Agriculture Organization of the United Nations (16 Oct 2014) (10/16/2014)

    The Committee on World Food Security (CFS) this week approved a landmark set of principles designed to guide investment in agriculture and food systems with the aim of assuring that cross-border and c... more

More News


Really, read some more.